FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hugo Cheinquer

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Drug Therapy, Combination

Concepts & Ideas

Co-author Network

Publications

TOP 3
Norberto C Chávez-Tapia; Hugo Cheinquer; Jorge Daruich; Milagros Dávalos-Moscol; Adrian Gadano; Claudio Marroni; Angelo Alves de Mattos; Fernando Bessone; Francisco Bosques-Padilla; Graciela Castro-Narro; Linda Muñoz-Espinoza; Raymundo Paraná; Ezequiel Ridruejo; Juan F Sánchez-Ávila; Alejandro Sosa; Misael Uribe; Rodrigo Zapata; Nahum Méndez-Sánchez
An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver .
Stephen A Harrison; Wlodzimierz Mazur; Michael McKenna; Diethelm Messinger; K Rajender Reddy; Maribel Rodriguez-Torres; Mitchell L Shiffman; Giovanni Faria Silva; Fernando Tatsch; Djamal Abdurakhmanov; Igor Bakulin; Hugo Cheinquer; Edward V Connell
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
Teerha Piratvisuth; Wattana Sukeepaisarnjaroen; Tawesak Tanwandee; Stefan Zeuzem; Fernando Bessone; Henry L Y Chan; Hugo Cheinquer; Jorge Daruich; Yuhong Dong; Eduardo Fassio; Piyawat Komolmit; Suzane K Ono; Rashidkhan Pathan; Mário G Pessôa; Aldo Trylesinski
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hugo Cheinquer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Norberto C Chávez-Tapia; Hugo Cheinquer; Jorge Daruich; Milagros Dávalos-Moscol; Adrian Gadano; Claudio Marroni; Angelo Alves de Mattos; Fernando Bessone; Francisco Bosques-Padilla; Graciela Castro-Narro; Linda Muñoz-Espinoza; Raymundo Paraná; Ezequiel Ridruejo; Juan F Sánchez-Ávila; Alejandro Sosa; Misael Uribe; Rodrigo Zapata; Nahum Méndez-Sánchez
An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver .
Annals of hepatology 2013;12 Suppl 2():3-35.
2013: Stephen A Harrison; Wlodzimierz Mazur; Michael McKenna; Diethelm Messinger; K Rajender Reddy; Maribel Rodriguez-Torres; Mitchell L Shiffman; Giovanni Faria Silva; Fernando Tatsch; Djamal Abdurakhmanov; Igor Bakulin; Hugo Cheinquer; Edward V Connell
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
Journal of clinical gastroenterology 2013;47(3):271-9.
2013: Teerha Piratvisuth; Wattana Sukeepaisarnjaroen; Tawesak Tanwandee; Stefan Zeuzem; Fernando Bessone; Henry L Y Chan; Hugo Cheinquer; Jorge Daruich; Yuhong Dong; Eduardo Fassio; Piyawat Komolmit; Suzane K Ono; Rashidkhan Pathan; Mário G Pessôa; Aldo Trylesinski
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.
PloS one 2013;8(2):e54279.
2012: Patrick Marcellin; Denis Ouzan; Massimo Puoti; Maribel Rodriguez-Torres; Manuela Schmitz; Mitchell L Shiffman; Fernando Tatsch; Hugo Cheinquer; Manuela Curescu; Geoffrey M Dusheiko; Peter Ferenci; Andrzej Horban; Donald Jensen; Gabriella Lengyel; Alessandra Mangia; Mario Rizzetto
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials.
Hepatology (Baltimore, Md.) 2012;56(6):2039-50.
2012: Silvia Coelho-Borges; Luciano Krug; Fernando Herz Wolff; Hugo Cheinquer; Nelson Cheinquer; Patricia Ashton-Prolla
Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin.
Arquivos de gastroenterologia 2012;49(1):9-13.
2012: Mario G Pessôa; Giovanni F Silva; Edison R Parise; Maria Patelli J S Lima; Hugo Cheinquer; Marco A Lacerda; Rosângela Teixeira; Suelene S Pedrosa; José R B Pernambuco; Paulo R L Almeida; Raymundo Paraná; Hoel Sette; Fernando Tatsch
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial.
Annals of hepatology 2012;11(1):52-61.
2011: Adrian Gadano; Omar Galdame; Cristina Galoppo; Miguel Garassini; Nelia Hernández; Sebastián Marciano; Angelo Mattos; Raymundo Paraná; Mario Pessoa; Jaime Poniachik; Gilda Porta; Marcelo Silva; Esteban González Ballerga; Fernando Bessone; Hugo Cheinquer; Jorge Daruich; Milagros Dávalos; Hugo Faimboin; Eduardo Fassio; Jorge Ferrandiz; Hugo Tanno; Edna Strauss
[Latin American guideline for the management of chronic hepatitis B].
Acta gastroenterologica Latinoamericana 2011;41(4):340-50.
2011: Yun-Fan Liaw; Robert P Myers; Cheng-Yuan Peng; Maria Raptopoulou-Gigi; Shiv Kumar Sarin; Shijie Tang; Tawesak Tanwandee; Naoky Tsai; Suzanne Beebe; Jolanta Bialkowska; Robert S Brown; Hugo Cheinquer; Lennox Jeffers; Nancy Leung; Elizabeth Cooney
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.
Hepatology (Baltimore, Md.) 2011;54(1):91-100.
2011: Markus Peck-Radosavljevic; John Boletis; Fatih Besisik; Maria Lúcia Ferraz; Laurent Alric; Didier Samuel; Diethelm Messinger; Andreas Tietz; Hugo Cheinquer
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(3):242-8.
2010: K Rajender Reddy; Mitchell L Shiffman; Maribel Rodriguez-Torres; Hugo Cheinquer; Djamal Abdurakhmanov; Igor Bakulin; Viacheslav Morozov; Giovanni Faria Silva; Natalia Geyvandova; Carol Stanciu; Michael Rabbia; Michael McKenna; James A Thommes; Stephen A Harrison
Induction pegylated interferon alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads.
Gastroenterology 2010;139(6):1972-83.
2010: Nelson Cheinquer; Hugo Cheinquer; Fernando H Wolff; Silvia Coelho-Borges
Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2010;14(5):457-61.
2010: D R Silva; J Stifft; Hugo Cheinquer; M M Knorst
Prevalence of hepatitis C virus infection in patients with COPD.
Epidemiology and infection 2010;138(2):167-73.
2009: Ting-Tsung Chang; Y-C Chao; V V Gorbakov; Kwang-Hyub Han; Robert G Gish; R de Man; Hugo Cheinquer; F Bessone; H Brett-Smith; R Tamez
Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.
Journal of viral hepatitis 2009;16(11):784-9.
2009: Marcelo Eidi Nita; Nelson Gaburo; Hugo Cheinquer; Gilbert L'Italien; Evaldo Stanislau Affonso de Araujo; Patricia Mantilla; Nancy Cure-Bolt; Paulo A Lotufo
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status.
Annals of hepatology 2009;8(4):339-45.
2009: Daniel Shouval; Ching-Lung Lai; Ting-Tsung Chang; Hugo Cheinquer; Paul Martin; Giampiero Carosi; Steven Han; Sabahattin Kaymakoglu; Ricardo Tamez; Joanna Yang; Daniel Tenney; Helena Brett-Smith
Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.
Journal of hepatology 2009;50(2):289-95.
2007: Jorge Daruich; Adrian Gadano; Hugo Fainboim; Mario Pessoa; Hugo Cheinquer
[Latin American guideline for the treatment of chronic hepatitis B].
Acta gastroenterologica Latinoamericana 2007;37(3):168-77.
2006: Nelia Hernández; Ruby Chirino; Eduardo Fassio; Hugo Cheinquer
[Hepatitis A and B vaccines].
Revista de gastroenterología de México 2006;71 Suppl 2():73-89.
2006: Bruno Galperim; Hugo Cheinquer; Airton Stein; André Fonseca; Vagner Lunge; Nilo Ikuta
Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors.
Arquivos de gastroenterologia 2006;43(2):81-4.
2006: Ching-Lung Lai; Daniel Shouval; Anna S F Lok; Ting-Tsung Chang; Hugo Cheinquer; Zachary Goodman; Deborah DeHertogh; Richard Wilber; Richard C Zink; Anne Cross; Richard J Colonno; Lori Fernandes
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
The New England journal of medicine 2006;354(10):1011-20.
2006: E Parise; Hugo Cheinquer; D Crespo; A Meirelles; A Martinelli; H Sette; J Gallizi; R Silva; C Lacet; E Correa; Helma P Cotrim; J Fonseca; Raymundo Paraná; V Spinelli; W Amorim; Fernando Tatsch; Mario Pessoa
Peginterferon alfa-2a (40KD) (PEGASYS) plus ribavirin (COPEGUS) in retreatment of chronic hepatitis C patients, nonresponders and relapsers to previous conventional interferon plus ribavirin therapy.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2006;10(1):11-6.
2005: Sirlei Dittrich; Angelo Alves de Mattos; Hugo Cheinquer; Fernanda Branco de Araújo
[Correlation between platelet blood levels and the hepatic venous pressure gradient among patients with cirrhosis].
Arquivos de gastroenterologia 2005;42(1):35-40.
2004: Sean D Sullivan; D M Jensen; D E Bernstein; T I Hassanein; G R Foster; S S Lee; Hugo Cheinquer; Antonio Craxi; Graham Cooksley; winslow klaskala; K Pettit; Kavita K Patel; Jesse Green
Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.
The American journal of gastroenterology 2004;99(8):1490-6.
2004: Bruno Galperim; Hugo Cheinquer; Airton Stein; André Fonseca; Vagner Lunge; Nilo Ikuta
Intranasal cocaine use does not appear to be an independent risk factor for HCV infection.
Addiction (Abingdon, England) 2004;99(8):973-7.
2003: Sirlei Dittrich; Angelo Alves de Mattos; Maicon Becker; Daniel Maffasioli Gonçaves; Hugo Cheinquer
Role of hepatic hemodynamic study in the evaluation of patients with cirrhosis.
Hepato-gastroenterology 2003;50(54):2052-6.
2002: Silvia Coelho-Borges; Hugo Cheinquer; Nelson Cheinquer; Luciano Krug; Patrícia Ashton-Prolla
HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.
The American journal of gastroenterology 2002;97(6):1570-2.
1996: L P Krug; V R Lunge; N Ikuta; A S Fonseca; Hugo Cheinquer; L S Ozaki; S G Barros
Hepatitis C virus genotypes in Southern Brazil.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 1996;29(12):1629-32.
1995: Lennox Jeffers; M E Coelho-Little; Hugo Cheinquer; C Vargas; Francisco Civantos; L Alvarez; K R Reddy; T Parker; M de Medina; X Li
Procollagen-III peptide and chronic viral C hepatitis.
The American journal of gastroenterology 1995;90(9):1437-40.
1994: Lennox Jeffers; I Alzate; H Aguilar; K R Reddy; V Idrovo; Hugo Cheinquer; F A Hasan; T Parker; C Montero; Gordon M Dickinson
Laparoscopic and histologic findings in patients with the human immunodeficiency virus.
Gastrointestinal endoscopy 1994;40(2 Pt 1):160-4.
1993: TSANYANG LIANG; Lennox Jeffers; K R Reddy; M de Medina; I T Parker; Hugo Cheinquer; V Idrovo; A Rabassa; Eugene R Schiff
Viral pathogenesis of hepatocellular carcinoma in the United States.
Hepatology (Baltimore, Md.) 1993;18(6):1326-33.
1993: L S Mitchel; Lennox Jeffers; K R Reddy; Hugo Cheinquer; E Coelho-Little; R Moreda; T Parker; M Silva; X M Li; M de Medina
Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
The American journal of gastroenterology 1993;88(7):1027-34.
1993: TSANYANG LIANG; Lennox Jeffers; R K Reddy; M O Silva; Hugo Cheinquer; A Findor; M de Medina; P O Yarbough; G R Reyes; Eugene R Schiff
Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses.
Gastroenterology 1993;104(2):556-62.